
|Articles|October 15, 2002
Head-to-head trial: Phase III study tests options for wet AMD
Fort Worth, TX-Alcon Research Ltd. is enrolling about 500 patients in a phase III study to compare the effects of anecortave acetate versus verteporfin (Visudyne, Novartis) photodynamic therapy for the treatment of wet age-related macular degeneration.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
OT Roundup ep. 1: ADHD's eye link, MOGENRY's BLA, and myopia news
2
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
3
Addressing geographic variation in dry eye disease care requires patient-centric approaches
4
Geographic atrophy featured across EURETINA 2026 scientific programme
5











